Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
19.41
-0.82 (-4.05%)
At close: May 18, 2026, 4:00 PM EDT
19.41
0.00 (0.00%)
Pre-market: May 19, 2026, 6:45 AM EDT

Syndax Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,7201,8361,1331,8331,7331,204
Market Cap Growth
44.66%62.10%-38.20%5.75%44.02%13.03%
Enterprise Value
1,7041,424551.551,2561,250777.36
Last Close Price
19.4121.0113.2221.6125.4521.89
PE Ratio
--6.39-3.55-7.25-10.3547.59
PS Ratio
7.9210.6547.84--8.61
PB Ratio
41.2928.413.933.313.712.95
P/TBV Ratio
40.6428.163.932.743.312.87
P/FCF Ratio
--5.68-4.12-11.41-12.9741.50
P/OCF Ratio
--5.69-4.12-11.41-12.9741.32
EV/Sales Ratio
7.858.2623.29--5.56
EV/EBITDA Ratio
--5.21-1.62-5.46-8.2429.60
EV/EBIT Ratio
--5.21-1.62-5.46-8.2429.65
EV/FCF Ratio
--4.41-2.01-7.82-9.3526.80
Debt / Equity Ratio
0.020.020.010.000.000.05
Debt / EBITDA Ratio
-0.01-0.01-0.01-0.01-0.010.80
Debt / FCF Ratio
0.000.00-0.01-0.01-0.010.72
Net Debt / Equity Ratio
-8.65-6.38-2.02-1.04-1.03-1.04
Net Debt / EBITDA Ratio
1.611.511.712.513.19-16.21
Net Debt / FCF Ratio
1.291.272.113.593.62-14.68
Asset Turnover
0.430.270.04000.37
Inventory Turnover
0.260.424.51---
Quick Ratio
4.884.015.749.9416.7921.60
Current Ratio
5.474.405.8210.0016.8521.68
Return on Equity (ROE)
-457.87%-161.82%-75.69%-40.98%-34.10%7.55%
Return on Assets (ROA)
-44.60%-43.54%-50.78%-41.43%-32.05%6.99%
Return on Invested Capital (ROIC)
-2021.15%-820.60%-1220.50%1517.50%917.13%-213.93%
Return on Capital Employed (ROCE)
-56.16%-52.98%-57.76%-44.96%-33.83%7.38%
Earnings Yield
-14.14%-15.66%-28.14%-13.79%-9.67%2.10%
FCF Yield
-16.18%-17.60%-24.27%-8.76%-7.71%2.41%
Buyback Yield / Dilution
-1.50%-1.17%-21.67%-15.82%-13.31%-29.81%
Total Shareholder Return
-1.50%-1.17%-21.67%-15.82%-13.31%-29.81%
Updated Apr 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q